Novavax files for authorisation of Covid-19 shot among adolescents in Britain


Share post:

Novavax Inc said on Wednesday (May 4) it had filed an application with The Medicines and Healthcare products Regulatory Agency for the authorisation of its Covid-19 vaccine among adolescents aged 12 and older.

The medicines regulator had in February cleared the two-dose vaccine, Nuvaxovid, for use in adults amid a spike in cases fuelled by the Omicron variant of the coronavirus.

Novavax’s submission includes data from a late-stage trial in the United States, where the vaccine showed 80 per cent efficacy among adolescents when Delta was the dominant variant in the country.

The drugmaker in late January filed for emergency use authorisation of its Covid-19 shot for adults in the United States.

The U.S. Food and Drug Administration plans to hold several meetings of its outside panel of experts in June to discuss authorisation requests submitted by multiple Covid-19 vaccine manufacturers including Novavax.


Please enter your comment!
Please enter your name here

Current Issue October 2023

Related articles

England lost more than 1,000 pharmacies in the last eight years, says CCA

Community pharmacies are currently facing a worrying mix of funding, workforce, and workload pressures The Company Chemists’ Association...

NHS care delays led to 112 deaths, harmed 8,000 people in England last year

The number of patients dying due to care delays have risen more than fivefold over the last three...

Whitworth Chemists puts six high-dispensing Blackpool pharmacies up for sale

The family-owned business has decided to sell all 34 pharmacies across the North of England Whitworth Chemists Limited...

Babies born with Wolman disease can now receive a life-saving treatment on the NHS

The new enzyme replacement therapy improves patient’s life expectancy and quality of life in clinical trials   For the first...